| 000 | 01820 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517022957.0 | ||
| 264 | 0 | _c20160817 | |
| 008 | 201608s 0 0 eng d | ||
| 022 | _a1651-226X | ||
| 024 | 7 |
_a10.3109/0284186X.2015.1009638 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTrip, Anouk K | |
| 245 | 0 | 0 |
_aRecent trends and predictors of multimodality treatment for oesophageal, oesophagogastric junction, and gastric cancer: A Dutch cohort-study. _h[electronic resource] |
| 260 |
_bActa oncologica (Stockholm, Sweden) _cNov 2015 |
||
| 300 |
_a1754-62 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAcademic Medical Centers _xtrends |
| 650 | 0 | 4 |
_aAdenocarcinoma _xpathology |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xpathology |
| 650 | 0 | 4 |
_aChemoradiotherapy, Adjuvant _xstatistics & numerical data |
| 650 | 0 | 4 |
_aChemotherapy, Adjuvant _xstatistics & numerical data |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 |
_aCombined Modality Therapy _xstatistics & numerical data |
| 650 | 0 | 4 |
_aEsophageal Neoplasms _xpathology |
| 650 | 0 | 4 | _aEsophagogastric Junction |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 | _aNetherlands |
| 650 | 0 | 4 |
_aStomach Neoplasms _xpathology |
| 700 | 1 | _aStiekema, Jurriën | |
| 700 | 1 | _aVisser, Otto | |
| 700 | 1 | _aDikken, Johan L | |
| 700 | 1 | _aCats, Annemieke | |
| 700 | 1 | _aBoot, Henk | |
| 700 | 1 | _avan Sandick, Johanna W | |
| 700 | 1 | _aJansen, Edwin P M | |
| 700 | 1 | _aVerheij, Marcel | |
| 773 | 0 |
_tActa oncologica (Stockholm, Sweden) _gvol. 54 _gno. 10 _gp. 1754-62 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3109/0284186X.2015.1009638 _zAvailable from publisher's website |
| 999 |
_c24731142 _d24731142 |
||